Abstract:The transcription factor RUNX1 is often mutated in acute myeloid leukemia. Familial platelet disorder with associated myeloid malignancy (FPDMM) is caused by mutations in RUNX1 and is associated with an increased risk of leukemia. Many FPDMM patients have heightened inflammation. Inflammation can promote malignancies and understanding how RUNX1 mutations increase inflammation is critical for determining how to halt leukemia progression. We created a pan hematopoietic RUNX1 knockout (KO) mouse model and found that RUNX1 KO neutrophils overproduced cytokines in response to toll-like receptor 4 (TLR4) stimulation with lipopolysaccharide (LPS). The hyper-responsiveness of RUNX1 KO neutrophils correlated with increased expression of several genes encoding proteins in the TLR4 pathway. To determine if RUNX1 regulates TLR4 signaling in neutrophils, we deleted RUNX1 specifically in neutrophils. Unexpectedly, RUNX1 deletion did not cause an inflammatory phenotype, indicating that alterations in the TLR4 signaling pathway are established in a neutrophil precursor. Single cell transcriptomic data suggests that RUNX1 deficiency dysregulates TLR4 signaling in a precursor of neutrophils, specifically the granulocyte-monocyte progenitor (GMP) population. We determined that RUNX1 loss in GMPs was sufficient to establish the inflammatory phenotype in neutrophils. We performed ATAC-seq and found that RUNX1 loss led to chromatin opening at key TLR signaling genes. We determined that the inflammatory phenotype driven by the IRF and STAT family of transcription factors. Together this data suggests that the dysregulated inflammatory response of neutrophils is a downstream consequence of RUNX1 deletion in GMPs and can be dampened by inhibiting either the TLR4 or JAK/STAT signaling pathways. The transcription factor RUNX1 is often mutated in acute myeloid leukemia. Familial platelet disorder with associated myeloid malignancy (FPDMM) is caused by mutations in RUNX1 and is associated with an increased risk of leukemia. Many FPDMM patients have heightened inflammation. Inflammation can promote malignancies and understanding how RUNX1 mutations increase inflammation is critical for determining how to halt leukemia progression. We created a pan hematopoietic RUNX1 knockout (KO) mouse model and found that RUNX1 KO neutrophils overproduced cytokines in response to toll-like receptor 4 (TLR4) stimulation with lipopolysaccharide (LPS). The hyper-responsiveness of RUNX1 KO neutrophils correlated with increased expression of several genes encoding proteins in the TLR4 pathway. To determine if RUNX1 regulates TLR4 signaling in neutrophils, we deleted RUNX1 specifically in neutrophils. Unexpectedly, RUNX1 deletion did not cause an inflammatory phenotype, indicating that alterations in the TLR4 signaling pathway are established in a neutrophil precursor. Single cell transcriptomic data suggests that RUNX1 deficiency dysregulates TLR4 signaling in a precursor of neutrophils, specifically the granulocyte-monocyte progenitor (GMP) population. We determined that RUNX1 loss in GMPs was sufficient to establish the inflammatory phenotype in neutrophils. We performed ATAC-seq and found that RUNX1 loss led to chromatin opening at key TLR signaling genes. We determined that the inflammatory phenotype driven by the IRF and STAT family of transcription factors. Together this data suggests that the dysregulated inflammatory response of neutrophils is a downstream consequence of RUNX1 deletion in GMPs and can be dampened by inhibiting either the TLR4 or JAK/STAT signaling pathways.

Transcription Repressor Hes1 is a Selective Regulator of TLR-induced CXCL1 Expression and Neutrophil Responses (IRM5P.708)

234: Selective regulation of CXCL1 expression and neutrophil responses by transcription repressor Hes1

The transcriptional repressor Hes1 attenuates inflammation by regulating transcription elongation

Human Homolog of Drosophila Hairy and Enhancer of Split 1, Hes1, Negatively Regulates Δ-Catenin (CTNND2) Expression in Cooperation with E2F1 in Prostate Cancer

Hes1 attenuates type I IFN responses via VEGF-C and WDFY1

Selective regulation of cytokine and chemokine expression by the Notch pathway

Epithelial Hes1 maintains gut homeostasis by preventing microbial dysbiosis

Cis-acting Lnc-Cxcl2 Restrains Neutrophil-Mediated Lung Inflammation by Inhibiting Epithelial Cell CXCL2 Expression in Virus Infection

Notch1 Contributes to TNF-α-induced Proliferation and Migration of Airway Smooth Muscle Cells Through Regulation of the Hes1/PTEN Axis.

The Role of Heat Shock Factor 1 in Transcriptional Regulation of High Mobility Group Box

Histone lysine methyltransferase Ezh1 promotes TLR-triggered inflammatory cytokine production by suppressing Tollip

CREB1-driven CXCR4 hi neutrophils promote skin inflammation in mouse models and human patients

Runx1 Negatively Regulates Inflammatory Cytokine Production by Neutrophils in Response to Toll-like Receptor Signaling.

ID: 123

Latexin deficiency in mice up-regulates inflammation and aggravates colitis through HECTD1/Rps3/NF-κB pathway

Cell-Specific Regulation of Inflammatory Cytokines and Acute-Phase Proteins by the Glucocorticoid Receptor

Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense

CXCL17 is a proinflammatory chemokine and promotes neutrophil trafficking

3239 – DETERMINING THE MECHANISM BY WHICH RUNX1 LOSS LEADS TO AN INFLAMMATORY RESPONSE IN HEMATOPOIETIC CELLS

Heme Oxygenase-1 Directly Binds Stat3 To Control The Generation Of Pathogenic Th17 Cells During Neutrophilic Airway Inflammation

The Myeloid Heat Shock Transcription Factor 1/-Catenin Axis Regulates Nlr Family, Pyrin Domain-Containing 3 Inflammasome Activation In Mouse Liver Ischemia/Reperfusion Injury